Conducting collaborative research locally, nationally and globally.

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

https://doi.org/10.1186/s12961-024-01150-6
Int J Drug Policy.gif
elsevier.jpg Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review
Created by Cayley Russell, Jenna Ashley, Farihah Ali, Nikki Bozinoff, Kim Corace, David Marsh, Christopher Mushquash, Jennifer Wyman, Maria Zhang, Shannon Lange
Daily supervised Opioid Agonist Treatment (OAT) medication has been identified as a barrier to treatment retention. Canadian OAT guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical…
  • No labels

The Institute for Mental Health Policy Research
Centre for Addiction and Mental Health
33 Ursula Franklin Street (Ursula Franklin and Spadina)
Toronto ON - M5S 2S1